Bio-inspired protein-gold nanoconstruct with core-void-shell structure: beyond a chemo drug carrier.

Chemotherapy has been widely used in clinical practice for cancer treatment. A major challenge for a successful chemotherapy is to potentiate the anticancer activity, whilst reducing the severe side effects. In this context, we design a bio-inspired protein-gold nanoconstruct (denoted as AFt-Au hereafter) with a core-void-shell structure which exhibits a high selectivity towards carcinoma cells. Anticancer drug 5-fluorouracil (5-FU) can be sequestered into the void space of the construct to produce an integrated nanoscale hybrid AFt-AuFU that exhibits an increased cellular uptake of 5-FU. More importantly, AFt-Au, serving as a bio-nano-chemosensitizer, renders carcinoma cells more susceptible to 5-FU by cell-cycle regulation, and thus, leads to a dramatic decrease of the IC50 value (i.e. the drug concentration required to kill 50% of the cell population) of 5-FU in HepG2 cells from 138.3 µM to 9.2 µM. Besides HepG2 cells, a remarkably enhanced anticancer efficacy and potentially reduced side effects are also achieved in other cell lines. Our further work reveals that the drug 5-FU is internalized into cells with AFt-Au primarily via receptor-mediated endocytosis (RME). After internalization, AFt-AuFU colocalizes with lysosomes which trigger the release of 5-FU under acidic conditions. Overall, our approach provides a novel procedure in nanoscience that promises an optimal chemotherapeutic outcome.

[Qualitative and quantitative analysis of fluoxetine hydrochloride by 19F NMR].

The chemical shift of fluoxetine hydrochloride appears at delta 14.15 in 19F NMR analysis. The delta moved upfield slightly from 14.158 to 14.145 when the concentration of solution became diluted from 2.00 to 0.05 mmol x L(-1). Spiking test was suggested to confirm the existence of the compound for qualitative analysis. 19F NMR detection sensitivity test illustrated that a concentration of 17 mg in 1 L water could be detected while the sample was scanned 500 times with optimum parameters. In quantitative analysis, standard curve of concentration versus fluorine signal intensity was proposed to determine the amount of fluoxetine. Long capillary tube containing trifluoroacetic acid was used as internal standard for the integration measurements and straight line was obtained with good fitting. Direct additions of trifluoroethanol to fluoxetine solutions gave a poorer standard curve.

Demicellization of a mixture of cationic-anionic hydrogenated/fluorinated surfactants through selective inclusion by alpha- and beta-cyclodextrin.

The interactions between alpha- and beta-cyclodextrin (alpha-/beta-CD) and an equimolar mixture of octyltriethylammonium bromide (OTEAB) and sodium perfluorooctanoate (SPFO) were studied by 1H and 19F NMR, surface tension, conductivity, and dynamic light scattering. It was shown that beta-CD could destroy the mixed micelles of OTEAB-SPFO by selective inclusion of SPFO. As beta-CD was added, the system was observed to undergo a process like this: beta-CD preferentially included SPFO to form 1:1 beta-CD/SPFO complexes. As the inclusion of SPFO was almost saturated, the mixed micelles broke and all OTEAB was released and exposed to aqueous surroundings. Then 1:1 beta-CD/OTEAB and 2:1 beta-CD/SPFO complexes significantly formed simultaneously. Contrary to beta-CD, alpha-CD exhibited selective inclusion to OTEAB and only weak association with SPFO. alpha-CD could also destroy the mixed micelles of OTEAB-SPFO; however, the demicellization ability of alpha-CD is much smaller than that of beta-CD. These conclusions were also well supported by the calculations of binding constants and DeltaG degrees . Different from the complexes of CD/conventional surfactants, the complexes of beta-CD/SPFO or alpha-CD/OTEAB formed by selective inclusion of CD in the mixed cationic-anionic surfactants may have contributed to the surface activity of the aqueous mixtures. The complexes of alpha-CD/OTEAB showed much more significant contribution to the surface activity than that of the complexes of beta-CD/SPFO.

NMR studies on selectivity of beta-cyclodextrin to fluorinated/hydrogenated surfactant mixtures.

The interactions between beta-cyclodextrin (beta-CD) and the equimolar/nonequimolar mixtures of sodium perfluorooctanoate (C(7)F(15)COONa, SPFO) and sodium alkyl sulfate (C(n)H(2n+1)SO(4)Na, C(n)SO(4), n = 8, 10, 12) were investigated by 1H and 19F NMR. It showed that beta-CD preferentially included the fluorinated surfactant when exposed to mixtures of hydrogenated (C(n)SO(4)) and fluorinated (SPFO) surfactants, notwithstanding whether the hydrogenated surfactant C(n)SO(4) was more or less hydrophobic than the SPFO. Such preferential inclusion of the fluorinated surfactant continued to a certain concentration of beta-CD at which time the C(n)SO(4) was then observed to be included. The longer the hydrocarbon chain of C(n)SO(4) the lower the concentration of beta-CD at which the hydrogenated surfactants began to show inclusion. The inclusion process can be qualitatively divided into three stages: first, formation of 1:1 beta-CD/SPFO complexes; second, formation of 1:1 beta-CD/C(n)SO(4) complexes; and finally, formation of 2:1 beta-CD/SPFO complexes upon further increase of beta-CD concentration. In the concentration range studied, during the last stage of inclusion both 2:1 beta-CD/C(12)SO(4) and 2:1 beta-CD/SPFO complexes appear to be simultaneously formed in the system of beta-CD/SPFO/C(12)SO(4) but not in either the systems of beta-CD/SPFO/C(8)SO(4) or beta-CD/SPFO/C(10)SO(4). The selective inclusion of the shorter fluorocarbon chain surfactant might be attributed to the greater rigidity and size of the fluorocarbon chains, compared to those of the hydrocarbon chains, which provide for a tighter fit and better interaction between the host and guest. This latter effect appears to dominate the increase in hydrophobic character as the carbon chain length increases in the hydrogenated series.

The design, synthesis, and biological evaluation of novel substituted purines as HIV-1 Tat-TAR inhibitors.

A series of novel substituted purines containing a side chain with a terminal amino or guanidyl group were designed and synthesized as HIV-1 Tat-TAR inhibitors. All the compounds could effectively block the TAR transactivation in human 293T cells with the CAT expression percentage ranging from 34.4% to 65.7% and showed high antiviral effects with low cytotoxicities in inhibiting the formation of SIV-induced syncytium in CEM174 cells. Molecular modeling studies by Auto-dock process suggest that the compounds bind to TAR RNA in two different modes.